P, W., S, D., S, W., Y, Z., J, B., A, S., . . . S, L. (2026). Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models. Science translational medicine, 18(852), eaea0189. https://doi.org/10.1126/scitranslmed.aea0189
Chicago Style (17th ed.) CitationP, Wang, et al. "Reprogrammed Apoptotic Platelets Drive Rapid Hemostasis Through Phosphatidylserine and Prostaglandin E2 Signaling in Preclinical Models." Science Translational Medicine 18, no. 852 (2026): eaea0189. https://doi.org/10.1126/scitranslmed.aea0189.
MLA (9th ed.) CitationP, Wang, et al. "Reprogrammed Apoptotic Platelets Drive Rapid Hemostasis Through Phosphatidylserine and Prostaglandin E2 Signaling in Preclinical Models." Science Translational Medicine, vol. 18, no. 852, 2026, p. eaea0189, https://doi.org/10.1126/scitranslmed.aea0189.